Considering the low or even unmeasurable serum levels of sclerostin in Van Buchem disease and sclerosteosis, the thought that high sclerostin levels lead to loss of bone mass and bone strength with an increased fracture risk is obvious. The gene discussed is SOST; the disease is hyperostosis corticalis generalisata.